Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,762.00
Bid: 4,760.00
Ask: 4,764.00
Change: 48.00 (1.02%)
Spread: 4.00 (0.084%)
Open: 4,734.00
High: 4,762.00
Low: 4,730.00
Prev. Close: 4,714.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

25 Jun 2007 07:02

Intertek Group PLC25 June 2007 25 June 2007, 7:00am (UK) Pre-close Trading Statement Intertek Group plc ("Intertek"), the leading international provider of qualityand safety services to a wide range of industries, today reports on tradingahead of entering the close period for the six months ending 30th June 2007. Theinterim results will be announced on Monday 3rd September 2007. The Group is expected to perform well in the first half. Growth in global tradeand increased demand for quality and safety services internationally continue tostimulate good growth in Intertek's industries and service lines. Through astrategy of offering added-value services to customers' products and processesand supporting them in their global trade, Intertek is continuing to gain fromthese positive industry trends. Consumer Goods continues to perform well in all major lines, with the increasedtextiles, toys and hardlines exports from China and Asia to the West driving thegrowth. Last year the division benefited from an increase in testing from thenew European Union legislation on Restriction of Hazardous Substances (RoHS).Subsequent limited enforcement of the legislation has reduced RoHS testing suchthat the divisional margin in the first half will be slightly lower compared tolast year. The Commercial & Electrical division is performing well in all three globalregions and has successfully increased market share and recognition of the ETLmark in the US over the period. There has been a turnaround in the automotivecomponents testing business which is no longer declining and is now showingpositive growth, although is still below the divisional average. The division isexpected to benefit from increased testing and certification for energyefficiency, particularly on lighting and electrical products manufactured inAsia. The recently acquired business including the ASTA and BEAB certificationmarks further strengthens Intertek's existing mark portfolio and ability toprovide manufacturers with seamless global market access.The strong performance in the Oil, Chemical and Agri division has been driven byhigh demand and trade in petroleum products, alongside the growth in biofuelsand ultra low sulphur diesel and the continued success of the outsourcingstrategy in the analytical services sector. Analytical services now account forover 50% of the division by revenue. Acquisitions in the upstream oil and gasmarket, minerals and pharmaceutical sectors this year are expanding the servicerange to existing customers and bringing new business into the network. Goodmarket conditions and increased testing volumes in higher margin analyticalservices will result in another period of positive margin up-lift in the firsthalf. The Government Services division is growing well on an underlying basis. Asanticipated it will report an overall decline in revenue and profit due to theinclusion of three months revenue and profit from the discontinued Nigeriacontract in 2006. There are good prospects for continuing the diversification ofthe revenue stream away from pre-shipment inspection. As previously announced, the level of external and internal investment hasincreased and over £50 million has been spent on six acquisitions so far thisyear. All of these are bringing additional services into the group or expansioninto new regions. The Group also continues to develop new services internallyand, by the end of the first half of 2007, approximately £1 million will havebeen spent. Internal and external investments will ensure new growthopportunities are captured.With approximately 80% of the Group's earnings in US dollar and US dollarrelated currencies, and the US dollar being currently 11% weaker againststerling than this time last year, on translation the results will be negativelyimpacted in the first half. The Board is pleased with the continuing good progress the group is making incapturing the growth in the industry and expect the results for the year to bein line with expectations. -ends- ContactsAston SwiftTelephone: +44 (0) 20 7396 3400aston.swift@intertek.com Richard Mountain / Susanne Yule, Financial DynamicsTelephone: +44 (0) 20 7831 3113richard.mountain@fd.com / susanne.yule@fd.com Notes to Editors ABOUT INTERTEKIntertek is the leading international provider of quality and safety services toa wide range of global and local industries. Partnership with Intertek bringsincreased value to customers' products and processes, ultimately supportingtheir success in the global market place. Intertek has the experience,expertise, resources and global reach to support its customers through itsnetwork of 930 laboratories and offices and over 18,000 people in 109 countriesaround the world. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Jun 20241:00 pmRNSDirector/PDMR Shareholding
29th May 20241:00 pmRNSDirector/PDMR Shareholding
28th May 20247:00 amRNSDirectorate Change
24th May 20241:30 pmRNSResult of AGM
24th May 20247:00 amRNSTrading Statement
22nd May 20241:00 pmRNSBlock listing Interim Review
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.